Serological data analyses show that adenovirus 36 infection is associated with obesity: A meta-analysis involving 5739 subjects

Obesity

Volumn 22, Issue 3, 2014, Pages 895-900

  Shang, Qinglong ^a,b,c   Wang, Haiping ^a   Song, Yujia ^d   Wei, Lanlan ^a,b,c   Lavebratt, Catharina ^e,f   Zhang, Fengmin ^a,b,c   Gu, Hongxi ^a,b,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Key Laboratory of Infection and Immunity   (China)

^c Heilongjiang Higher Education Institutions   (China)

^d HARBIN UNIVERSITY   (China)

^e KAROLINSKA INSTITUTE   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS 36 INFECTION; ADENOVIRUS INFECTION; ADULT; BODY MASS; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SEROLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; CONFIDENCE INTERVALS; DATABASES, FACTUAL; HUMANS; OBESITY; ODDS RATIO; RISK FACTORS;

EID: 84895785432     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20533     Document Type: Review

References (40)

1. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK,. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008; 16: 2323-2330.
2. International Obesity Task Force. (2013) [WWW document]. URL http://www.iotf.org/aboutobesity.asp.
3. Robinson SM, Godfrey KM,. Feeding practices in pregnancy and infancy: relationship with the development of overweight and obesity in childhood. Int J Obes (Lond) 2009; 32: S4-S10.
4. Leskinen T, Sipilä S, Alen M, et al. Leisure-time physical activity and high-risk fat: a longitudinal population-based twin study. Int J Obes (Lond) 2009; 33: 1211-1218.
5. Mustelin L, Silventoinen K, Pietiläinen K, Rissanen A, Kaprio J,. Physical activity reduces the influence of genetic effects on BMI and waist circumference: a study in young adult twins. Int J Obes (Lond) 2009; 33: 29-36.
6. Dhurandhar NV,. Infectobesity: obesity of infectious origin. J Nutr 2001; 131: 2794S-2797S.
7. Wigand R, Gelderblom H, Wadell G,. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol 1980; 64: 225-233.
8. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL,. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000; 24: 989-996.
9. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL,. Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 2001; 25: 990-996.
10. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV,. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004; 12: 770-777.
11. Pasarica M, Mashtalir N, McAllister EJ, et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem cells 2008; 26: 969-978.
12. Krishnapuram R, Dhurandhar EJ, Dubuisson O, et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779-E789.
13. Trovato GM, Martines GF, Garozzo A, et al. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184-190.
14. Atkinson RL, Dhurandhar NV, Allison DB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286.
15. Na HN, Kim J, Lee HS, et al. Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) 2012; 36: 281-285.
16. Broderick MP, Hansen CJ, Irvine M, et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond) 2010; 34: 302-308.
17. Lau J, Ioannidis JP, Schmid CH,. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
18. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
19. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
20. Munafo MR, Clark TG, Flint J,. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 2004; 129: 39-44.
21. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res ed) 1997; 315: 629-634.
22. Palla L, Higgins JP, Wareham NJ, Sharp SJ,. Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol 2010; 171: 1225-1232.
23. Rogers PM, Mashtalir N, Rathod MA, et al. Netabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 2008; 57: 2321-2331.
24. Wang ZQ, Gefalu WT, Zhang XH, et al. 2008, Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008; 57: 1805-1813.
25. Vangipuram SD, Yu M, Tian J, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007; 31: 87-96.
26. Na HN, Kim H, Nam JH,. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Int J Obes (Lond) 2012; 36: 195-200.
27. Wang ZQ, Yu Y, Zhang XH, Floyd EZ, Cefalu WT,. Human adenovirus 36 decreases fatty acid oxidation and increases de novo lipogenesis in primary cultured human skeletal muscle cells by promoting Cidec/FSP27 expression. Int J Obes (Lond) 2010; 34: 1355-1364.
28. Rathod MA, Rogers PM, Vangipuram SD, McAllister EJ, Dhurandhar NV,. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity (Silver Spring) 2009; 17: 657-664.
29. Rogers PM, Fusinski KA, Rathod MA, et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond) 2008; 32: 397-406.
30. Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ,. Infection-induced inflammatory response of adipocytes in vitro. Int J Obes (Lond) 2008; 34: 1355-1364.
31. Na HN, Nam JH,. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Disease 2012; 205: 914-922.
32. Yamada T, Hara K, Kadowaki T,. Association of Adenovirus 36 Infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. PLoS ONE 2012; 7: e42031.
33. Milner JJ, Beck MA,. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012; 71: 298-306.
34. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH,. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2010; 34: 89-93.
35. Atkinson RL, Lee I, Shin HJ, He J,. Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 2010; 5: 157-160.
36. Gabbert C, Donohue M, Arnold J, Schwimmer JB,. Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010; 126: 721-726.
37. Almgren M, Atkinson R, He J, et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS ONE 2012; 7: e41652.
38. Goossens VJ, deJager SA, Grauls GE, et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) 2011; 19: 220-221.
39. Lin WY, Dubuisson O, Rubicz R, et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care 2013; 36: 701-707.
40. Trovato GM, Castro A, Tonzuso A, et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402-1409.